|
Match
|
Document |
Document Title |
|
|
US20090286837 |
Oxadiazole compounds as urokinase inhibitors
The present invention relates to novel compounds which inhibit urokinase-plasminogen activator (uPA), have a high bioavailability and can be administered orally, and to their use as therapeutic...
|
|
|
US20090285888 |
DERIVATIVES OF DIHYDROXYPHENYLALANINE
The invention relates to derivatives of dihydroxyphenylalanine, to their synthesis and to pharmaceutical compositions containing said derivatives of dihydroxyphenylalanine. Furthermore, the...
|
|
|
US20090264497 |
STABLE PHARMACEUTICAL FORMULATION COMPRISING A HMG-COA REDUCTASE INHIBITOR
Lovastatin, pravastatin, simvastatin, mevastatin, atorvastatin, and derivatives and analogs thereof are known as HMG-CoA reductase inhibitors and are used as antihypercholesterolemic agents. The...
|
|
|
US20090239941 |
AMINO ACID DERIVATIVES
Compounds of formula (I) are active as dopaminergic compounds or as compounds which or as compounds which diminish the symptoms of dopamine deficiency: wherein: R 1 and R 2 are independently...
|
|
|
US20090221620 |
GENTIC POLYMORPHISMS ASSOCIATED WITH STROKE, METHODS OF DETECTION AND USES THEREOF
The present invention provides compositions and methods based on genetic polymorphisms that are associated with vascular diseases such as stroke. In particular, the present invention relates to...
|
|
|
US20090221527 |
TUMOR NECROSIS FACTOR INHIBITORS
The present invention is directed to compounds that are allosteric inhibitors of tumor necrosis factor receptor I, compositions comprising such compounds, and methods of using such compounds and...
|
|
|
US20090215881 |
Polyphenolic Bioprecursors
Cosmetic and therapeutic, in particular dermatological bioprecursors have the formula [A] n —PP—[B] m wherein PP is a polyphenol radical in which each hydroxyl function is protected by a group...
|
|
|
US20090203774 |
SUBSTITUTED BENZYL ESTER DERIVATIVE AND USE THEREOF
The present invention relates to a pharmaceutical composition, a food composition or a cosmetic composition, containing one or more kinds of a compound represented by the following formula (I′) ...
|
|
|
US20090196920 |
PHARMACEUTICAL COMPOSITION COMPRISING MICROCAPSULES OF STATINS SUSPENDED IN ALKYL ESTERS OF POLYUNSATURATED FATTY ACIDS (PUFA)
The invention relates to a pharmaceutical composition comprising a suspension consisting of an oil with a high concentration of alkyl esters of polyunsaturated fatty acids (PUFA) and to...
|
|
|
US20090163476 |
N-Phenyl Benzamide Derivatives as Sirtuin Modulators
Provided herein are novel sirtuin-modulating compounds and methods of use thereof. The sirtuin-modulating compounds may be used for increasing the lifespan of a cell, and treating and/or preventing...
|
|
|
US20090155349 |
METHODS OF TREATING INFLUENZA VIRAL INFECTIONS
Methods are described for treating an influenza viral infection or associated diseases, disorders or mechanisms in a subject, comprising administering to the subject a therapeutically effective...
|
|
|
US20090130232 |
Composition and method for treatment of oral inflammation an ulceration
The present invention is a composition and method for treating oral lesions. A composition for treatment of oral lesions may comprise: (a) an anesthetic composition; (b) an antifungal composition;...
|
|
|
US20090117181 |
Tablet comprising fluvastatin and carmellose calcium
The present invention relates to a fluvastatin-containing tablet, particularly a fluvastatin-containing tablet which has excellent disintegrating property and good bioavailability.
|
|
|
US20090105338 |
DEUTERIUM-ENRICHED GABEXATE MESYLATE
The present application describes deuterium-enriched gabexate mesylate, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
|
|
|
US20090093652 |
Crystalline forms cinacalcet fumarate and cinacalcet succinate and processes for preparation thereof
The present invention provides crystalline forms of Cinacalcet Fumarate and Cinacalcet Succinate, pharmaceutical compositions comprising the crystalline form of Cinacalcet Fumarate and/or the...
|
|
|
US20090093510 |
Use of Nitrooxyderivatives of Drug for the Treatment of Muscular Dystrophies
The present invention relates to the use of nitric oxide releasing compounds for retarding or reversing muscular dystrophies such as Duchenne and Becker dystrophies.
|
|
|
US20090076148 |
DEUTERIUM-ENRICHED PRAVASTATIN
The present application describes deuterium-enriched pravastatin, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
|
|
|
US20090076136 |
THERAPEUTIC AGENT
The present invention relates to a therapeutic agent or prophylactic agent for a disease accompanying an abnormality in an amount of insulin or insulin response, an insulin-mimetic action agent, a...
|
|
|
US20090068143 |
ORALLY EFFECTIVE CANNABINOID ANALOGS
The present invention relates to orally effective ligands of the peripheral cannabinoid receptor CB 2 , especially (+)-α-pinene derivatives, and to pharmaceutical compositions thereof, which are...
|
|
|
US20080319068 |
Novel Polymorph of Acetylsalicylic Acid, and Methods of Making and Using the Same
A polymer of aspirin is provided by the present invention. Methods of making and using the same are also provided.
|
|
|
US20080300304 |
Ginger Fraction For Inhibiting Human Cyp Enzymes
The present invention relates to a process for preparing a ginger fraction, the fraction prepared by this process and the use thereof on its own or combined with drugs for inhibiting human...
|
|
|
US20080293812 |
Use of pamoic acid or one of its derivatives, or one of its analogues, for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregates
Pamoic acid or its derivatives of formula (I) are used to treat diseases characterized by deposits of amyloid aggregates.
|
|
|
US20080280979 |
Methods and Compositions of Derivatives of Probucol for the Treatment of Diabetes
This present invention provides methods and pharmaceutical compositions for the treatment or prophylaxis of diabetes and related disorders, comprising the administration of an effective amount of a...
|
|
|
US20080260837 |
Physically stable aqueous suspensions of active pharmaceuticals
The present invention concerns methods of making physically stable aqueous suspensions of sparingly soluble to insoluble in water, active pharmaceuticals. More particularly, the invention provides...
|
|
|
US20080242725 |
Pharmaceutical Composition
Stabilized pharmaceutical compositions comprising polymorphs of active pharmaceutical ingredients susceptible to conversion to alternate polymorph forms are prepared by a process of wet granulation...
|
|
|
US20080242724 |
Ibopamine Maleate, Method for Preparing it and Pharmaceutical Compositions Containing It
Ibopamine malcate salt (1:1), method for preparing it and pharmaceutical composition containing it.
|
|
|
US20080161348 |
PTX3-GENE EXPRESSION INHIBITOR
A method for suppressing expression of PTX 3 gene, which comprises administering an effective amount of a compound, which is represented by the following formula ( 1 ):
wherein R 1 represents...
|
|
|
US20080160087 |
Gel preparation for oral administration
Provided for use in medical care settings is a gel preparation for oral administration to patients with hyperlipemia or hypercholesterolemia, wherein the ingestibility of an HMG-CoA reductase...
|
|
|
US20080125486 |
Use of 2,5-Dihydroxybenzene Compounds and Derivatives for the Treatment of Hematological Dyscrasias and Cancer of an Organ
The present invention refers to the use of the compound of Formula (I′) or pharmaceutically acceptable salt, solvate, isomer, or prodrug thereof for the treatment and/or prophylaxis of...
|
|
|
US20080125485 |
Use of 2,5-Dihydroxybenzene Derivatives for Treating Actinic Keratosis
The present invention relates to the use of a 2,5-dihydroxybenzene derivative represented by Formula (I) or a pharmaceutically acceptable salt, solvate, isomer, or prodrug thereof for the...
|
|
|
US20080114063 |
Use of 2,5-Dihydroxybenzene Derivatives for the Treatment of Tissue Reactive Diseases
The present invention relates to the use of a compound of Formula (I′) or pharmaceutically acceptable salt, solvate, isomer, or prodrug thereof for the treatment and/or prophylaxis of any of the...
|
|
|
US20080113948 |
Use of 2,5-Dihydroxybenzene Compounds and Derivatives for the Treatment of Psoriasis
The present invention relates to the use of a 2,5-dihydroxybenzene derivative of formula (I) or a pharmaceutically acceptable salt, solvate, isomer, or prodrug thereof for the treatment and/or...
|
|
|
US20080113947 |
Use of 2,5-Dihydroxybenzene Compounds and Derivatives for the Treatment of Rosacea
The present invention relates to the use of a 2,5-dihydroxybenzene derivative of formula (I) or a pharmaceutically acceptable salt, solvate, isomer, or prodrug thereof for the treatment and/or...
|
|
|
US20080113934 |
USE OF DIPYRIDAMOLE OR MOPIDAMOL FOR TREATMENT AND PREVENTION OF FIBRIN-DEPENDENT MICROCIRCULATION DISORDERS
A method of treatment of the human or non-human animal body for treating fibrin-dependent microcirculation disorders is disclosed, for example, microcirculation disorders caused by metabolic...
|
|
|
US20080103201 |
Novel alpha-Glucosidase inhibitor from Tabernaemontana dichotoma
This invention is directed to a novel pharmacological property of β-Amyrin acetate derived from Tabernaemontana dichotoma as a potent α-glycosidase inhibitor, which has not been reported...
|
|
|
US20080085933 |
Aqueous compositions containing monoester salts
Clear aqueous compositions comprising water, a hydrophobic organic compound, and from about 2 to about 50 wt. % of a solubilizer are disclosed. The solubilizer is an alkali metal or alkaline earth...
|
|
|
US20080085911 |
STATIN AND OMEGA-3 FATTY ACIDS FOR REDUCTION OF APO-B LEVELS
Methods of utilizing a combined administration or a unit dosage of a combination of an HMG-CoA inhibitor and omega-3 fatty acids for the reduction of apolipoprotein-B levels. The methods are...
|
|
|
US20080075772 |
PHARMACEUTICAL COMPOSITIONS HAVING NOVEL SCORING PATTERNS AND METHODS OF USING THOSE COMPOSITIONS
The invention provides novel scoring patterns for a wide variety of tablets that contain specific drugs or contain drugs in certain drug classes, and methods of treatment with layered tablets and...
|
|
|
US20080044475 |
Absorption and bioavailability of carotenoids, formulations and applications
A process for obtaining a microscopic physical state of xanthophylls or oxycarotenoids derivatives forms such as diacetates or dipropionates derivatives, which are readily incorporated in the...
|
|
|
US20080014152 |
INTRANASAL DELIVERY OF CLENBUTEROL ACROSS THE CRIBRIFORM PLATE AND INTO THE BRAIN
The intranasal delivery of an effective amount of NGF inducers, such as clenbuterol, to the brain.
|